Comparative Effectiveness of Myofacial Release vs Cupping Therapy on Quality of Life in Restless Leg Syndrome With Knee O.A.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-70
SponsorDow University of Health Sciences

About this trial

The aim of this study is to determine effectiveness of Myofascial Release and Cupping Therapy on Quality of Life in Restless Leg Syndrome with knee Osteoarthritis. Holding this aim, a Randomized control trial will be conducted at physiotherapy out patient department of Dow Institute of Physical Medicine and Rehabilitation.

The subjects will first be screened by the principal investigator, physiotherapist, using the criteria of International Restless Leg Syndrome Study Group (IRLSSG). Each selected subject will go for random allocation in one of the two treatment groups with different interventions with the help of a computer-generated randomization sheet. The group A will be provided with myofacial release whereas the group B will receive cupping therapy while cryotherapy and passive lower limb stretches (hamstring and calf muscles) will be applied to both the groups as standard treatment. Assessment will be done at baseline and will re-evaluate at the post intervention session through an assessment form. Physical therapist but not the principal investigator will assess who will be unaware to the type of intervention administered.

Outcome measures will be Pittsburgh sleep quality index, Visual Analog Scale for pain assessment, Restless leg syndrome Quality of life questionnaire (RLS-QOL), International Restless leg syndrome Study Group Rating Scale (IRLSSG RS) and passive straight leg raise (PSLR). Total 12 sessions will be given for duration of 4weeks on alternate days.

Eligibility criteria

Qualifiers

grade 2, 3 and 4 knee OA by the Kellgren Lawrence classification

Bilateral or unilateral both knee OA

Age 40 to 70 years

Patients who were meeting the International Restless Leg Syndrome Study Group (IRLSSG) eligibility criteria

Disqualifiers

patients with cognitive dysfunction

Rheumatoid arthritis

patients with neurological disorders

Medical conditions covering (cardiovascular disease, neurological disorders, severe psychiatric illness or pregnancy)

Trial design

Treatments tested in this trial

  • Myofacial release
  • Dynamic cupping therapy

Treatment groups

54 Participants
are divided into 2 treatment groups